SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XILLIX FDA APPROVED -- Ignore unavailable to you. Want to Upgrade?

To: Edward W. Richmond who wrote (408)5/21/1999 12:55:00 AM
From: hsg  Read Replies (1) | Respond to of 572
 
agreed. the market is potentially huge...where are the top line revenues...Olympus distrubution looked like a huge win at the time...still, potentially it could payoff as XLX creates new/innovative products that catch medical researchers/purchasers attention...I believe we are sitting on a winner that could reach double digits over the next couple of years.



To: Edward W. Richmond who wrote (408)5/25/1999 11:32:00 AM
From: hsg  Read Replies (1) | Respond to of 572
 
continues it's positive momentum. If it keep this up it could draw in some new investors. Looks like it will crack $1.40 (offered at $1.39, bid at $1.35). Cool. Nice move.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News